Back to search
FDAFDA · Food and drugs·Recall number D-0768-2021

Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903

Published September 1, 2021 · Recall initiated: August 10, 2021

Summary

FDA records drug Class II recall D-0768-2021, published September 1, 2021 and initiated August 10, 2021. Recalling firm: SterRx, LLC; Status: Terminated; Reported quantity: 3378 bags; Lot: Lot Numbers: BTW, exp. date 03/08/22 BUI, exp. date 03/16/22. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SterRx, LLC
Distributor
Nationwide in the US
Lot
Lot Numbers: BTW, exp. date 03/08/22 BUI, exp. date 03/16/22
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903 recalled?

Yes. FDA published recall D-0768-2021 on September 1, 2021. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Press Release